RESEARCH

Pharmaceutical Economics,
Big Data Analysis & Policy Lab

Projects

ongoing Evidence-Based Study to Evaluate the Clinical Effectiveness of Blue Blood Cells for Secondary Prevention in Ischemic Stroke Patients and to Expand Indications for Stroke Sequelae

본문

.

PERIOD: 2022.04.01-2026.11.30